vs
Side-by-side financial comparison of Eastman Chemical Company (EMN) and RENAISSANCERE HOLDINGS LTD (RNR). Click either name above to swap in a different company.
RENAISSANCERE HOLDINGS LTD is the larger business by last-quarter revenue ($2.2B vs $2.0B, roughly 1.1× Eastman Chemical Company). RENAISSANCERE HOLDINGS LTD runs the higher net margin — 23.5% vs 5.3%, a 18.2% gap on every dollar of revenue. On growth, Eastman Chemical Company posted the faster year-over-year revenue change (-13.8% vs -36.8%). Over the past eight quarters, Eastman Chemical Company's revenue compounded faster (-8.6% CAGR vs -11.9%).
Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures.
EMN vs RNR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $2.2B |
| Net Profit | $105.0M | $515.8M |
| Gross Margin | 17.1% | — |
| Operating Margin | — | — |
| Net Margin | 5.3% | 23.5% |
| Revenue YoY | -13.8% | -36.8% |
| Net Profit YoY | -42.3% | 72.6% |
| EPS (diluted) | $0.93 | $6.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | $2.2B | ||
| Q4 25 | $2.0B | $3.0B | ||
| Q3 25 | $2.2B | $3.2B | ||
| Q2 25 | $2.3B | $3.2B | ||
| Q1 25 | $2.3B | $3.5B | ||
| Q4 24 | $2.2B | $2.3B | ||
| Q3 24 | $2.5B | $4.0B | ||
| Q2 24 | $2.4B | $2.8B |
| Q1 26 | $105.0M | $515.8M | ||
| Q4 25 | $105.0M | $760.5M | ||
| Q3 25 | $47.0M | $916.5M | ||
| Q2 25 | $140.0M | $835.4M | ||
| Q1 25 | $182.0M | $170.0M | ||
| Q4 24 | $330.0M | $-189.7M | ||
| Q3 24 | $180.0M | $1.2B | ||
| Q2 24 | $230.0M | $503.9M |
| Q1 26 | 17.1% | — | ||
| Q4 25 | 17.1% | — | ||
| Q3 25 | 19.7% | — | ||
| Q2 25 | 22.1% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 24.7% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | 25.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 42.5% | ||
| Q3 25 | 6.1% | 46.3% | ||
| Q2 25 | 7.4% | 41.8% | ||
| Q1 25 | 11.0% | -2.0% | ||
| Q4 24 | 13.2% | -3.6% | ||
| Q3 24 | 11.4% | 43.7% | ||
| Q2 24 | 12.1% | 25.0% |
| Q1 26 | 5.3% | 23.5% | ||
| Q4 25 | 5.3% | 25.6% | ||
| Q3 25 | 2.1% | 28.7% | ||
| Q2 25 | 6.1% | 26.1% | ||
| Q1 25 | 7.9% | 4.9% | ||
| Q4 24 | 14.7% | -8.3% | ||
| Q3 24 | 7.3% | 29.8% | ||
| Q2 24 | 9.7% | 17.8% |
| Q1 26 | $0.93 | $6.57 | ||
| Q4 25 | $0.93 | $16.16 | ||
| Q3 25 | $0.40 | $19.40 | ||
| Q2 25 | $1.20 | $17.20 | ||
| Q1 25 | $1.57 | $3.27 | ||
| Q4 24 | $2.81 | $-3.76 | ||
| Q3 24 | $1.53 | $22.62 | ||
| Q2 24 | $1.94 | $9.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $566.0M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.0B | $4.3B |
| Total Assets | $14.9B | $53.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $566.0M | $1.6B | ||
| Q4 25 | $566.0M | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $837.0M | $1.7B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | $6.0B | $4.3B | ||
| Q4 25 | $6.0B | $11.6B | ||
| Q3 25 | $5.8B | $11.5B | ||
| Q2 25 | $5.8B | $10.8B | ||
| Q1 25 | $5.9B | $10.3B | ||
| Q4 24 | $5.8B | $10.6B | ||
| Q3 24 | $5.7B | $11.2B | ||
| Q2 24 | $5.6B | $10.2B |
| Q1 26 | $14.9B | $53.7B | ||
| Q4 25 | $14.9B | $53.8B | ||
| Q3 25 | $15.0B | $54.5B | ||
| Q2 25 | $15.2B | $54.7B | ||
| Q1 25 | $15.0B | $53.6B | ||
| Q4 24 | $15.2B | $50.7B | ||
| Q3 24 | $15.1B | $52.8B | ||
| Q2 24 | $14.9B | $51.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
